![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig1_HTML.png)
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
![Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - ScienceDirect Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500218303775-pl1.jpg)
Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - ScienceDirect
![Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17300974-gr2.jpg)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
![PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/75c7a5a10a62339b88fe5157b0ecc21dd7bfacd8/2-Table3-1.png)
PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar
![Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3347_0.png)
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
![PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer](https://www.researchgate.net/profile/Joachim-Pawel/publication/242354126/figure/tbl1/AS:393144983146496@1470744476082/Useful-and-potentially-useful-markers-for-lung-cancer_Q320.jpg)
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
![Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/2729/public/2729-PB3-R1.png/w300)
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
![Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9cbea13732ed9f9299e409d9fb7b272385d2ae69/7-Table4-1.png)
Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
![Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3eb8aeb3ef0e5fbd41ccaac4c356ef547e9dadef/22-Table2-1.png)
Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar
![Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8ca3c249142cbe1d4e92eefae11e9bfcb042c18c/3-Table1-1.png)
Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar
![Differences of tumor markers between male lung cancer patients with and... | Download Scientific Diagram Differences of tumor markers between male lung cancer patients with and... | Download Scientific Diagram](https://www.researchgate.net/publication/339544771/figure/tbl1/AS:863359473823747@1582852347702/Differences-of-tumor-markers-between-male-lung-cancer-patients-with-and-without-OM.png)